Xianjian Technology (01302.HK): Increased R&D investment, looking forward to continuous gains in the innovation pipeline

中金公司Mar 30 11:00

Xianjian Technology (01302.HK): Internationalization accelerates and enhances core products to continue to excel

廣發證券Sep 4, 2023 00:36

Sihuan Pharmaceutical (00460.HK): Botox Restorative Growth, Pharmaceutical Multi-Pipeline Research and Development Bureau Drives Performance Pressure

德邦證券Aug 31, 2023 11:00

Xianjian Technology (01302.HK): In line with expectations, innovative results continued to be harvested in the first half of the year

中金公司Aug 30, 2023 19:22

Sihuan Pharmaceutical (0460.HK) 23H1 Performance Forecast Review: Adhering to “Innovative Drug+Medical Aesthetics” Dual Wheel Drive Medical and Aesthetic Business Achieves High Growth

信達證券Aug 10, 2023 18:42

Four Ring Pharmaceuticals (0460.HK): Beginning with the platformization of Letibao Medical Aesthetics

德邦證券Jul 5, 2023 11:00

Xianjian Technology (01302.HK): Innovation and internationalization of established powerhouses of high-value consumables have entered a harvest period

中金公司Jun 16, 2023 11:00

Sihuan Pharmaceutical (0460.HK): Across the entire medical and aesthetic sector, biopharmaceutical research and development accelerated

天風證券Apr 17, 2023 11:00

Xianjian Technology (01302.HK): Steady growth in performance and abundant research pipelines

廣發證券Apr 3, 2023 18:11

Xianjian Technology (1302.HK): China's leading minimally invasive intervention innovation enterprise

安信國際Dec 22, 2022 10:00

Four-Ring Pharmaceutical (00460.HK): Collection Background: Innovation for Change in Medicine and Aesthetics+Pharmaceutical Two-wheel Drive

國盛證券Sep 18, 2022 21:41

Sihuan Pharmaceutical (00460.HK): Short-term uncertainty but optimistic about long-term growth potential

國泰君安國際Aug 31, 2022 11:00

Cyclic Pharmaceuticals (00460.HK): Growth can be expected

國泰君安國際Jul 15, 2022 11:00

Sihuan Pharmaceutical (00460.HK): 2022 will be the first year the medical aesthetic+biomedical two-wheel drive strategy is realized

國泰君安國際Jul 10, 2022 11:00

Sihuan Pharmaceutical (00460.HK): “Medical+Medical Aesthetics” dual-wheel drive medical and aesthetic business achieves high growth

東方財富證券Apr 26, 2022 17:51

Sihuan Pharmaceutical (00460.HK) Company Comment: Strong layout of medical and aesthetic sector to build leading medical aesthetic and biopharmaceutical enterprises

天風證券Apr 12, 2022 02:21

Xianjian Technology (01302.HK) Company Comment: 2021 Results Are in Line with Expectations, Adhere to Independent R&D and International Development

天風證券Apr 3, 2022 11:00

Sihuan Pharmaceutical (0460.HK) 2021 Annual Report Review: Revenue Increased by 34%, Cash Bulls Helping Medical Aesthetic+Innovative Drug Transformation

浙商證券Mar 31, 2022 11:00

Sihuan Pharmaceutical (00460.HK): Medical and aesthetic business is growing strongly and diversified product pipelines are gradually being implemented

華安證券Mar 30, 2022 03:31

Sihuan Pharmaceutical (0460.HK): Medical and aesthetic explosion, increased investment in innovative drugs

中泰證券Mar 29, 2022 11:00